
    
      A multi-center, open labelled, randomized study in healthy na誰ve adult subjects. Subjects
      were randomly assigned to groups A (60) and B (60). Group A as a control arm of the study,
      had received a commercially available rabies vaccine, RABIPUR速. Group B had received doses of
      the investigational PIKA rabies vaccine in an accelerated regimen.

      Group A followed the vaccine regimen of (1-1-1-1),one injection on days 0, 3, 7 and 14 was
      administered respectively. Group B received the accelerated regimen (2-2-1), two injections
      on both days 0 and 3 were administered in different arms余 and only one injection was
      administered on day 7.

      Each vaccine dose comprise 1.0 ml of PIKA rabies vaccine for Group B and 1.0 ml of RABIPUR速
      for Group A after reconstitution. The route of administration is intramuscular injection,
      given in the deltoid region of the arm.
    
  